Up­dat­ed: As­traZeneca says there’s ‘very lim­it­ed’ im­pact on Farx­i­ga af­ter US drug pric­ing ne­go­ti­a­tions

As­traZeneca has con­clud­ed its price ne­go­ti­a­tions with the IRA for its block­buster drug Farx­i­ga, in the lat­est up­date for phar­ma com­pa­nies un­der­go­ing the process. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER